- Acheter crypto
- Marchés
- Futures
- Spot
- Copy trading
WE-Launch
US Biopharmaceutical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB
BlockBeats News, July 28th, According to a report by businessinsider, Clinical-stage biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) today announced plans to strategically expand into the cryptocurrency and blockchain space.
The company plans to establish a subsidiary named "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to gradually raise and deploy up to $500 million in funds, with the goal of strategically long-term investing in BNB.
Liminatus emphasized that while the company remains fully committed to its core business - advancing cancer treatments and pancreatic cancer diagnostic technologies, expanding into the digital asset space is seen as a necessary step to support long-term growth and enhance shareholder value.
Liminatus is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer patients. The company is advancing a series of novel therapies targeting cancer antigens and tumor-specific immune responses.
Vous pourriez aussi aimer
À la hausse
Dernières actus crypto
Ethereum ICO Whale with 254,900 Tokens Nearing Liquidation, a déposé 23 000 ETH au CEX au cours de la semaine écoulée
La Banque centrale de Russie a confirmé qu'elle pourrait assouplir les règles de régulation des cryptomonnaies.
OCDE: S’attend à ce que la Réserve fédérale "abaisse progressivement" le taux directeur à 3,25% à 3,5%
Le géant de la gestion des actifs Tidal Investments acquiert environ 60 millions de dollars en actions stratégiques
Une certaine baleine avec une position short importante de BTC prévoit de longer autour de 67 000 $, avec un bénéfice de 26,83 millions de dollars actuellement.
Assistance client：@weikecs
Collaborations commerciales：@weikecs
Trading quantitatif/Market makers：[email protected]
Programme VIP：[email protected]
App